Integra LifeSciences Holdings Gross Margin 2010-2025 | IART
Current and historical gross margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current gross profit margin for Integra LifeSciences Holdings as of March 31, 2025 is %.
| Integra LifeSciences Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $1.63B | $0.87B | 53.48% |
| 2024-12-31 | $1.61B | $0.88B | 54.75% |
| 2024-09-30 | $1.57B | $0.86B | 54.89% |
| 2024-06-30 | $1.57B | $0.88B | 56.00% |
| 2024-03-31 | $1.53B | $0.86B | 56.12% |
| 2023-12-31 | $1.54B | $0.88B | 57.37% |
| 2023-09-30 | $1.54B | $0.91B | 58.88% |
| 2023-06-30 | $1.55B | $0.93B | 60.00% |
| 2023-03-31 | $1.56B | $0.97B | 62.04% |
| 2022-12-31 | $1.56B | $0.97B | 62.26% |
| 2022-09-30 | $1.57B | $0.97B | 61.88% |
| 2022-06-30 | $1.57B | $0.97B | 62.12% |
| 2022-03-31 | $1.56B | $0.96B | 61.79% |
| 2021-12-31 | $1.54B | $0.94B | 61.18% |
| 2021-09-30 | $1.53B | $0.94B | 61.40% |
| 2021-06-30 | $1.51B | $0.93B | 61.63% |
| 2021-03-31 | $1.38B | $0.84B | 61.25% |
| 2020-12-31 | $1.37B | $0.85B | 62.03% |
| 2020-09-30 | $1.38B | $0.86B | 62.05% |
| 2020-06-30 | $1.39B | $0.86B | 61.72% |
| 2020-03-31 | $1.51B | $0.94B | 62.37% |
| 2019-12-31 | $1.52B | $0.95B | 62.78% |
| 2019-09-30 | $1.51B | $0.94B | 62.68% |
| 2019-06-30 | $1.49B | $0.93B | 62.36% |
| 2019-03-31 | $1.48B | $0.92B | 62.37% |
| 2018-12-31 | $1.47B | $0.90B | 61.28% |
| 2018-09-30 | $1.46B | $0.89B | 60.70% |
| 2018-06-30 | $1.37B | $0.84B | 61.20% |
| 2018-03-31 | $1.29B | $0.79B | 61.62% |
| 2017-12-31 | $1.19B | $0.75B | 63.25% |
| 2017-09-30 | $1.08B | $0.70B | 65.24% |
| 2017-06-30 | $1.05B | $0.69B | 65.52% |
| 2017-03-31 | $1.01B | $0.66B | 65.38% |
| 2016-12-31 | $0.99B | $0.64B | 64.82% |
| 2016-09-30 | $0.98B | $0.62B | 63.87% |
| 2016-06-30 | $0.95B | $0.60B | 63.27% |
| 2016-03-31 | $0.92B | $0.58B | 63.25% |
| 2015-12-31 | $0.88B | $0.56B | 62.85% |
| 2015-09-30 | $0.80B | $0.50B | 62.52% |
| 2015-06-30 | $0.77B | $0.48B | 62.71% |
| 2015-03-31 | $0.79B | $0.49B | 62.17% |
| 2014-12-31 | $0.80B | $0.49B | 61.98% |
| 2014-09-30 | $0.73B | $0.45B | 61.52% |
| 2014-06-30 | $0.74B | $0.45B | 61.22% |
| 2014-03-31 | $0.72B | $0.43B | 60.56% |
| 2013-12-31 | $0.70B | $0.42B | 59.83% |
| 2013-09-30 | $0.83B | $0.51B | 60.84% |
| 2013-06-30 | $0.83B | $0.51B | 61.06% |
| 2013-03-31 | $0.83B | $0.51B | 61.73% |
| 2012-12-31 | $0.83B | $0.52B | 62.41% |
| 2012-09-30 | $0.82B | $0.51B | 61.71% |
| 2012-06-30 | $0.81B | $0.50B | 61.45% |
| 2012-03-31 | $0.80B | $0.49B | 61.26% |
| 2011-12-31 | $0.78B | $0.48B | 61.67% |
| 2011-09-30 | $0.77B | $0.48B | 62.73% |
| 2011-06-30 | $0.76B | $0.48B | 63.05% |
| 2011-03-31 | $0.74B | $0.47B | 63.43% |
| 2010-12-31 | $0.73B | $0.46B | 63.17% |
| 2010-09-30 | $0.72B | $0.46B | 63.62% |
| 2010-06-30 | $0.71B | $0.45B | 63.84% |
| 2010-03-31 | $0.70B | $0.44B | 63.88% |
| 2009-12-31 | $0.68B | $0.44B | 64.13% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.054B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.668B | 87.45 |
| Thermo Fisher Scientific (TMO) | United States | $151.715B | 18.35 |
| Edwards Lifesciences (EW) | United States | $45.473B | 29.82 |
| Alcon (ALC) | Switzerland | $43.302B | 29.26 |
| IDEXX Laboratories (IDXX) | United States | $42.214B | 48.51 |
| DexCom (DXCM) | United States | $33.984B | 52.53 |
| IQVIA Holdings (IQV) | United States | $26.351B | 14.76 |
| Mettler-Toledo (MTD) | United States | $24.614B | 29.27 |
| STERIS (STE) | Ireland | $23.975B | 26.41 |
| Waters (WAT) | United States | $20.898B | 29.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.583B | 0.00 |
| Hologic (HOLX) | United States | $14.336B | 15.58 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $10.026B | 78.69 |
| Masimo (MASI) | United States | $9.324B | 34.39 |
| Globus Medical (GMED) | United States | $8.112B | 19.33 |
| Teleflex (TFX) | United States | $5.426B | 8.96 |
| Glaukos (GKOS) | United States | $5.314B | 0.00 |
| TransMedics (TMDX) | United States | $4.703B | 102.24 |
| Integer Holdings (ITGR) | United States | $4.233B | 22.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.481B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.505B | 14.92 |
| Veracyte (VCYT) | United States | $2.151B | 30.18 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 23.53 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Alphatec Holdings (ATEC) | United States | $1.861B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.384B | 0.00 |
| Artivion (AORT) | United States | $1.236B | 115.80 |
| Pulse Biosciences (PLSE) | United States | $1.150B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.827B | 0.00 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.03 |
| RxSight (RXST) | United States | $0.611B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.567B | 13.30 |
| OrthoPediatrics (KIDS) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.497B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.390B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.368B | 9.79 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.342B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 49.20 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.29 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |